Showing results (141-150 of 240) with videos related to

Sort By:
Pageof 24
Schizophrenia Bulletin|October 2, 2013
Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categoriesJames L Reilly, Kyle Frankovich, Scot Hill, et al.
The American Journal of Psychiatry|December 11, 2024
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 TrialsWilliam P Horan, Colin Sauder, Philip D Harvey, et al.
Innovations in Clinical Neuroscience|July 25, 2013
Defining a clinically meaningful effect for the design and interpretation of randomized controlled trialsRichard S E Keefe, Helena C Kraemer, Robert S Epstein, et al.
The Journal of Behavioral Health Services & Research|February 5, 2008
Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophreniaSandra G Resnick, Robert A Rosenheck, Jose M Canive, et al.
Psychiatric Services (Washington, D.C.)|July 28, 2006
Baseline use of concomitant psychotropic medications to treat schizophrenia in the CATIE trialMiranda H Chakos, Ira D Glick, Alexander L Miller, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|April 28, 2020
Corticolimbic brain anomalies are associated with cognitive subtypes in psychosis: A longitudinal studyNew Fei Ho, Benjamin J H Lee, Jordon X J Tng, et al.
The Australian and New Zealand Journal of Psychiatry|April 28, 2007
AKT1 and neurocognition in schizophreniaAndrea Poyastro Pinheiro, Richard S E Keefe, Tara Skelly, et al.
Schizophrenia Research|November 26, 2008
Results of phase 3 of the CATIE schizophrenia trialT Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, et al.
Pageof 24